These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8488640)

  • 21. Comparison of the efficacy of cefadroxil and generic and proprietary cephalexin in the treatment of pyoderma in dogs.
    Frank LA; Kunkle GA
    J Am Vet Med Assoc; 1993 Aug; 203(4):530-3. PubMed ID: 8407508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of canine pyoderma with ibafloxacin and marbofloxacin--fluoroquinolones with different pharmacokinetic profiles.
    Horspool LJ; van Laar P; van den Bos R; Mawhinney I
    J Vet Pharmacol Ther; 2004 Jun; 27(3):147-53. PubMed ID: 15189300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of orbifloxacin tablets for the treatment of superficial and deep pyoderma due to Staphylococcus intermedius infection in dogs.
    Scott DW; Peters J; Miller WH
    Can Vet J; 2006 Oct; 47(10):999-1002. PubMed ID: 17078249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose assessment of 2% chlorhexidine acetate for canine superficial pyoderma.
    Murayama N; Terada Y; Okuaki M; Nagata M
    Vet Dermatol; 2011 Oct; 22(5):449-53. PubMed ID: 21392140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adherence of Staphylococcus intermedius to corneocytes of healthy and atopic dogs: effect of pyoderma, pruritus score, treatment and gender.
    Simou C; Thoday KL; Forsythe PJ; Hill PB
    Vet Dermatol; 2005 Dec; 16(6):385-91. PubMed ID: 16359305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of canine pyoderma with co-amoxyclav: a comparison of two dose rates.
    Lloyd DH; Carlotti DN; Koch HJ; Van den Broek AH
    Vet Rec; 1997 Oct; 141(17):439-41. PubMed ID: 9369001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacologic features of clindamycin in dogs and cats.
    Harari J; Lincoln J
    J Am Vet Med Assoc; 1989 Jul; 195(1):124-5. PubMed ID: 2759885
    [No Abstract]   [Full Text] [Related]  

  • 28. Canine superficial bacterial pyoderma: evaluation of skin surface sampling methods and antimicrobial susceptibility of causal Staphylococcus isolates.
    Ravens PA; Vogelnest LJ; Ewen E; Bosward KI; Norris JM
    Aust Vet J; 2014 May; 92(5):149-55. PubMed ID: 24766044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulsed-field gel electrophoresis patterns and antimicrobial susceptibility phenotypes for coagulase-positive staphylococcal isolates from pustules and carriage sites in dogs with superficial bacterial folliculitis.
    Pinchbeck LR; Cole LK; Hillier A; Kowalski JJ; Rajala-Schultz PJ; Bannerman TL; York S
    Am J Vet Res; 2007 May; 68(5):535-42. PubMed ID: 17472455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nasal carriage of Staphylococcus schleiferi from healthy dogs and dogs with otitis, pyoderma or both.
    May ER; Kinyon JM; Noxon JO
    Vet Microbiol; 2012 Dec; 160(3-4):443-8. PubMed ID: 22771206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pyoderma caused by Pseudomonas aeruginosa infection in dogs: 20 cases.
    Hillier A; Alcorn JR; Cole LK; Kowalski JJ
    Vet Dermatol; 2006 Dec; 17(6):432-9. PubMed ID: 17083575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular characterization of Staphylococcus intermedius carriage by healthy dogs and comparison of antimicrobial susceptibility patterns to isolates from dogs with pyoderma.
    Hartmann FA; White DG; West SE; Walker RD; Deboer DJ
    Vet Microbiol; 2005 Jun; 108(1-2):119-31. PubMed ID: 15917140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pradofloxacin in the treatment of canine deep pyoderma: a multicentred, blinded, randomized parallel trial.
    Mueller RS; Stephan B
    Vet Dermatol; 2007 Jun; 18(3):144-51. PubMed ID: 17470228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of the clinical efficacy of 0.2% topical stannous fluoride for the treatment of canine superficial pyoderma: a prospective, randomized, double-blinded, placebo-controlled trial.
    Seltzer JD; Flynn-Lurie AK; Marsella R; Brennan MM
    Vet Dermatol; 2010 Jun; 21(3):249-58. PubMed ID: 20230586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of meticillin-resistant Staphylococcus pseudintermedius (MRSP) from skin and carriage sites of dogs after treatment of their meticillin-resistant or meticillin-sensitive staphylococcal pyoderma.
    Beck KM; Waisglass SE; Dick HL; Weese JS
    Vet Dermatol; 2012 Aug; 23(4):369-75, e66-7. PubMed ID: 22364707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human recombinant interferonalpha-2b for management of idiopathic recurrent superficial pyoderma in dogs: a pilot study.
    Thompson LA; Grieshaber TL; Glickman L; Glickman N
    Vet Ther; 2004; 5(1):75-81. PubMed ID: 15150732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial drug susceptibility of Staphylococcus intermedius clinical isolates from canine pyoderma.
    Ganiere JP; Medaille C; Mangion C
    J Vet Med B Infect Dis Vet Public Health; 2005 Feb; 52(1):25-31. PubMed ID: 15702997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibiotic responsive ulcerative dermatoses in German Shepherd Dogs with mucocutaneous pyoderma.
    Bassett RJ; Burton GG; Robson DC
    Aust Vet J; 2004 Aug; 82(8):485-9. PubMed ID: 15359964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of a commercial staphylococcal bacterin for management of idiopathic recurrent superficial pyoderma in dogs.
    DeBoer DJ; Moriello KA; Thomas CB; Schultz KT
    Am J Vet Res; 1990 Apr; 51(4):636-9. PubMed ID: 2327626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prescribing practices of primary-care veterinary practitioners in dogs diagnosed with bacterial pyoderma.
    Summers JF; Hendricks A; Brodbelt DC
    BMC Vet Res; 2014 Oct; 10():240. PubMed ID: 25293803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.